DOI QR코드

DOI QR Code

Hair characteristics and androgenetic alopecia in Koreans

한국인의 두피모발 특성과 남성형탈모증

Choi, Gwang Seong
최광성

  • Published : 20130100

Abstract

The scalp hair is composed of one hundred thousand of hairs. Each hair goes through the three phases of the hair cycle, which causes the hair to turn from an anagen hair into a catagen hair, then into a telogen hair, and finally into a new anagen hair. The number of hairs is maintained at a relatively constant level because each hair has its own hair cycle. The hair of Koreans is relatively thicker than that of Caucasians and Africans but its growth rate and density are lower. There are various factors that influence hair growth such as hormones, nutritional status, and drugs. However, androgen is most important among these factors and, particularly, androgenetic alopecia is caused by androgen and genetic factors. Because excessive dihydrotestosterone produced by $5{\alpha}$-reductase is of the greatest importance in androgenetic alopecia, finasteride or dutasteride, which inhibits the action of $5{\alpha}$-reductase, is effective in treating androgenetic alopecia. Also, minoxidil is widely used as it promotes hair growth. Furthermore, there are various types of hair diseases and specialized examination is required for differential diagnosis.

Keywords

References

  1. Cotsarelis G, Botchkarev V. Disorders of the hair and nails. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick's dermatology in general medicine. 7th ed. New York: McGraw-Hill; 2008. p. 739-749
  2. Cotsarelis G, Millar SE, Chan EF. Embryology and anatomy of the hair follicle. In: Olsen EA, editor. Disorders of hair growth: diagnosis and treatment. 2nd ed. New York: McGraw-Hill; 2003. p. 15.
  3. Shapiro J. Hair loss: principles of diagnosis and management of alopecia. London: Martin Dunitz; 2002.
  4. Wolfram LJ, Dika E, Maibach HI. Hair anthropology. In: Berardesca E, Leveque JL, Maibach HI, editors. Ethnic skin and hair. New York: Informa Healthcare; 2006. p. 55-67
  5. Tajima M, Hamada C, Arai T, Miyazawa M, Shibata R, Ishino A. Characteristic features of Japanese women's hair with aging and with progressing hair loss. J Dermatol Sci 2007;45:93-103 https://doi.org/10.1016/j.jdermsci.2006.10.011
  6. Birch MP, Messenger JF, Messenger AG. Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol 2001;144:297-304 https://doi.org/10.1046/j.1365-2133.2001.04018.x
  7. Yoo JH, Park HY, Park TH, Kim KJ. Quantitative analysis on the scalp hair characteristics in Koreans using phototrichogram. Korean J Dermatol 2002;40:1035-1043
  8. Kang H, Kang TW, Lee SD, Park YM, Kim HO, Kim SY. The changing patterns of hair density and thickness in South Korean women with hair loss: clinical office-based phototri-chogram analysis. Int J Dermatol 2009;48:14-21 https://doi.org/10.1111/j.1365-4632.2009.03795.x
  9. Stenn KS, Paus R. Controls of hair follicle cycling. Physiol Rev 2001;81:449-494 https://doi.org/10.1152/physrev.2001.81.1.449
  10. Paus R, Muller-Rover S, Botchkarev VA. Chronobiology of the hair follicle: hunting the "hair cycle clock". J Investig Dermatol Symp Proc 2004;4:338-345.
  11. Rushton H, James KC, Mortimer CH. The unit area trichogram in the assessment of androgen-dependent alopecia. Br J Dermatol 1983;109:429-437 https://doi.org/10.1111/j.1365-2133.1983.tb04617.x
  12. Park YT, Yoo JH, Park TH, Kim KJ. Comparative evaluation of hair density and grouped hair unit pattern between androge-netic alopecia and normal scalp. Ann Dermatol 2004;16:1-8 https://doi.org/10.5021/ad.2004.16.1.1
  13. Haw S, Lew BL, Sim WY. The study of density and thickness of Koreans' scalp hair with aging. Korean J Dermatol 2008;46:161
  14. Park J, Ihm CW. Evaluation of the scalp hair mass of Koreans. Korean J Dermatol 2010;48:17-25
  15. Zouboulis CC, Chen WC, Thornton MJ, Qin K, Rosenfield R. Sexual hormones in human skin. Horm Metab Res 2007;39:85-95 https://doi.org/10.1055/s-2007-961807
  16. Shah D, Patel S. Hirsutism. Gynecol Endocrinol 2009;25:140-148 https://doi.org/10.1080/09513590802531567
  17. Alonso LC, Rosenfield RL. Molecular genetic and endocrine mechanisms of hair growth. Horm Res 2003;60:1-13
  18. Whiting DA. Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss. J Am Acad Dermatol 2001;45:S81-S86 https://doi.org/10.1067/mjd.2001.117428
  19. Hoffmann R. Male androgenetic alopecia. Clin Exp Dermatol 2002;27:373-382 https://doi.org/10.1046/j.1365-2230.2002.01086.x
  20. Randall VA. Androgens and hair growth. Dermatol Ther 2008;21:314-328 https://doi.org/10.1111/j.1529-8019.2008.00214.x
  21. Goldberg LJ, Lenzy Y. Nutrition and hair. Clin Dermatol 2010;28:412-419 https://doi.org/10.1016/j.clindermatol.2010.03.038
  22. Olsen EA. Iron deficiency and hair loss: the jury is still out. J Am Acad Dermatol 2006;54:903-906 https://doi.org/10.1016/j.jaad.2005.10.038
  23. Muller O, Krawinkel M. Malnutrition and health in developing countries. CMAJ 2005;173:279-286 https://doi.org/10.1503/cmaj.050342
  24. Bolland MJ, Ames RW, Grey AB, Horne AM, Mason BH, Gamble GD, Reid IR. Does degree of baldness influence vita-min D status?. Med J Aust 2008;189:674-675
  25. Tosi A, Misciali C, Piraccini BM, Peluso AM, Bardazzi F. Drug-induced hair loss and hair growth: incidence, management and avoidance. Drug Saf 1994;10:310-317 https://doi.org/10.2165/00002018-199410040-00005
  26. Tosti A, Pazzaglia M. Drug reactions affecting hair: diagnosis. Dermatol Clin 2007;25:223-231 https://doi.org/10.1016/j.det.2007.01.005
  27. Hamilton JB. Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat 1942;71:451-480 https://doi.org/10.1002/aja.1000710306
  28. Hoffmann R. Steroidogenic isoenzymes in human hair and their potential role in androgenetic alopecia. Dermatology 2003;206:85-95 https://doi.org/10.1159/000068475
  29. Lee WS, Oh Y, Ji JH, Park JK, W Kim do, Sim WY, Kim HO, Hwang SW, Yoon TY, Kye YC, Choi GS, Kim MB, Huh CH, Ro BI, Kim SJ, Kim JH, Lee Y. Analysis of familial factors using the basic and specific (BASP) classification in Korean patients with androgenetic alopecia. J Am Acad Dermatol 2011;65:40-47 https://doi.org/10.1016/j.jaad.2010.05.005
  30. Hillmer AM, Flaquer A, Hanneken S, Eigelshoven S, Kortum AK, Brockschmidt FF, Golla A, Metzen C, Thiele H, Kolberg S, Reinartz R, Betz RC, Ruzicka T, Hennies HC, Kruse R, Nothen MM. Genome-wide scan and fine-mapping linkage study of androgenetic alopecia reveals a locus on chromosome 3q26. Am J Hum Genet 2008;82:737-743 https://doi.org/10.1016/j.ajhg.2007.11.014
  31. Inui S, Itami S. Molecular basis of androgenetic alopecia: from androgen to paracrine mediators through dermal papilla. J Dermatol Sci 2011;61:1-6 https://doi.org/10.1016/j.jdermsci.2010.10.015
  32. Lee WS, Ro BI, Hong SP, Bak H, Sim WY, W Kim do, Park JK, Ihm CW, Eun HC, Kwon OS, Choi GS, Kye YC, Yoon TY, Kim SJ, Kim HO, Kang H, Goo J, Ahn SY, Kim M, Jeon SY, Oh TH. A new classification of pattern hair loss that is universal for men and women: basic and specific (BASP) classification. J Am Acad Dermatol 2007;57:37-46 https://doi.org/10.1016/j.jaad.2006.12.029
  33. Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002;47:377-385 https://doi.org/10.1067/mjd.2002.124088
  34. Park HY, Lee WS, Park J, Kim DW, Ahn SY, Jung YJ, Ro BI, Sim WY, Park SW, Choi GS, Kim HO, Huh CH, Yoon TY, Kim MB, Kim KH, Song H, Yun SJ. An open label, multi-center clinical trial of topical 5% minoxidil solution for the treatment of male androgenetic alopecia (a phase IV study). Korean J Dermatol 2009;47:295-302
  35. Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998;39:578-589 https://doi.org/10.1016/S0190-9622(98)70007-6
  36. Male Pattern Hair Loss Study Group Finasteride. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol 2002;12:38-49
  37. Kaufman KD, Rotonda J, Shah AK, Meehan AG. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss). Eur J Dermatol 2008;18:400-406
  38. Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML, Wilson T, Rittmaster RS. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a random-ized placebo-controlled study of dutasteride versus finaste-ride. J Am Acad Dermatol 2006;55:1014-1023 https://doi.org/10.1016/j.jaad.2006.05.007
  39. Eun HC, Kwon OS, Yeon JH, Shin HS, Kim BY, Ro BI, Cho HK, Sim WY, Lew BL, Lee WS, Park HY, Hong SP, Ji JH. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. J Am Acad Dermatol 2010;63:252-258 https://doi.org/10.1016/j.jaad.2009.09.018
  40. Olsen EA. Female pattern hair loss. J Am Acad Dermatol 2001;45:S70-S80 https://doi.org/10.1067/mjd.2001.117426

Cited by

  1. Effects of Weight Management Program for Middle Aged Women with Metabolic Syndrome Risk Factors vol.23, pp.2, 2013, https://doi.org/10.7570/kjo.2014.23.2.106
  2. 한양방 치료를 병행한 남성형 탈모 환자 4례 증례 보고 vol.30, pp.2, 2017, https://doi.org/10.6114/jkood.2017.30.2.170
  3. 조발성 탈모증과 대사증후군과의 관계: 체계적 문헌고찰 및 메타분석 vol.30, pp.3, 2013, https://doi.org/10.6114/jkood.2017.30.3.166
  4. 금잔화, 상황, 어성초 에탄올 추출물의 세포독성 평가 및 3T3-L1 세포에 대한 육모 효과 vol.25, pp.6, 2017, https://doi.org/10.7783/kjmcs.2017.25.6.404
  5. 한방모발관리 제품과 육미지황환(六味地黃丸)을 병용한 남성형 탈모 환자 치험 2례 vol.33, pp.1, 2020, https://doi.org/10.6114/jkood.2020.33.1.075
  6. Effect of Needle Geometry on Insertion Force of Different Hair Implanters vol.10, pp.None, 2013, https://doi.org/10.14326/abe.10.90